Microglia, the immune cells of the central nervous system, have long been a subject of study in the Alzheimer’s disease (AD) field due to their dramatic responses to the pathophysiology of the disease.
Alzheimer’s disease (AD) is the most common cause of dementia in North America. Growing evidence supports the concept that AD is a metabolic disease mediated by impairments in brain insulin responsiveness, glucose utilization, and energy…
Recently researchers proposed the term ‘Type-3-Diabetes’ for Alzheimer’s disease (AD) because of the shared molecular and cellular features among Type-1-Diabetes, Type-2-Diabetes and insulin resistance associated with memory deficits and…
Cognitive disorders of aging represent a serious threat to the social and economic welfare of current society. It is now widely recognized that pathology related to such conditions, particularly Alzheimer’s disease, likely begins years or…
Alzheimer’s disease (AD), is a progressive neurodegenerative disease that affects behavior, thinking, learning, and memory in elderly individuals. AD occurs in two forms, early onset familial and late-onset sporadic; genetic mutations in PS…
Lithium se dnes v medicíně používá jako antidepresivum. I když máme k dispozici mnoho sofistikovanějších prostředků/dalších generací antidepresiv, má stále své místo. Na některé zvlášť silné deprese/bipolární poruchy léky typu Prozacu či…
Quality nutrition is key to supporting our brain health as we age. If you are showing signs of decreased brainpower or loss of memory consider these nutrients.